Literature DB >> 15996578

Silk fibroin as a novel coating material for controlled release of theophylline.

Oguz Bayraktar1, Ozge Malay, Yarkin Ozgarip, Ayşegül Batigün.   

Abstract

The aim of this study was to explore potential use of the silk fibroin (SF) as an aqueous coating material for theophylline tablets. We have examined the film forming and coating properties of heat-treated fibroin, SF solution having different amounts of polyethylene glycol (PEG) and 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide (EDC) cross-linked SF. Heat-treated SF material possessed a brittle structure, which resulted in poor film forming and coating properties. The optimum PEG amount in SF solution was determined as 17% (by weight) for an acceptable film forming and zero order release profile. EDC cross-linked SF has shown a very good film forming and coating property with a potential for sustaining the drug release from coated theophylline tablets. Dissolution data for coated theophylline tablets were analyzed using Ritger and Peppas equation to describe the mechanism of drug release. Drug release from the EDC coated tablets followed zero-order kinetics. Release rate constants were found to be 0.26, 0.19, 0.16%min(-1) for single-coated, double coated, and triple coated tablets, respectively. These results clearly demonstrated that silk fibroin has high utility as a novel aqueous coating material for controlled release products.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996578     DOI: 10.1016/j.ejpb.2005.02.002

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  17 in total

Review 1.  Extended release formulations using silk proteins for controlled delivery of therapeutics.

Authors:  Burcin Yavuz; Laura Chambre; David L Kaplan
Journal:  Expert Opin Drug Deliv       Date:  2019-07-01       Impact factor: 6.648

2.  Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses.

Authors:  Xianyan Wang; Xiaohui Zhang; John Castellot; Ira Herman; Mark Iafrati; David L Kaplan
Journal:  Biomaterials       Date:  2007-11-28       Impact factor: 12.479

3.  Nanolayer biomaterial coatings of silk fibroin for controlled release.

Authors:  Xianyan Wang; Xiao Hu; Andrea Daley; Olena Rabotyagova; Peggy Cebe; David L Kaplan
Journal:  J Control Release       Date:  2007-06-14       Impact factor: 9.776

4.  Novel extraction and application of okra gum as a film coating agent using theophylline as a model drug.

Authors:  Ikoni J Ogaji; Stephen W Hoag
Journal:  J Adv Pharm Technol Res       Date:  2014-04

5.  A quicker degradation rate is yielded by a novel kind of transgenic silk fibroin consisting of shortened silk fibroin heavy chains fused with matrix metalloproteinase cleavage sites.

Authors:  Guoping Huang; Danfeng Yang; Chunfeng Sun; Jianping Huang; Keping Chen; Chunxia Zhang; Huiqing Chen; Qin Yao
Journal:  J Mater Sci Mater Med       Date:  2014-05-07       Impact factor: 3.896

6.  Effect of β-sheet crystalline content on mass transfer in silk films.

Authors:  Kiran A Karve; Eun Seok Gil; Stephen P McCarthy; David L Kaplan
Journal:  J Memb Sci       Date:  2011-11-01       Impact factor: 8.742

7.  Mechanisms of controlled release from silk fibroin films.

Authors:  Daniel J Hines; David L Kaplan
Journal:  Biomacromolecules       Date:  2011-01-20       Impact factor: 6.988

8.  Mulberry non-engineered silk gland protein vis-à-vis silk cocoon protein engineered by silkworms as biomaterial matrices.

Authors:  Joydip Kundu; Moumita Dewan; Sarani Ghoshal; S C Kundu
Journal:  J Mater Sci Mater Med       Date:  2008-02-19       Impact factor: 3.896

9.  Silk nanospheres and microspheres from silk/pva blend films for drug delivery.

Authors:  Xiaoqin Wang; Tuna Yucel; Qiang Lu; Xiao Hu; David L Kaplan
Journal:  Biomaterials       Date:  2009-11-27       Impact factor: 12.479

Review 10.  Silk-based biomaterials for sustained drug delivery.

Authors:  Tuna Yucel; Michael L Lovett; David L Kaplan
Journal:  J Control Release       Date:  2014-06-05       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.